📰 Chemical Optimization News

Chemical Optimization News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Chemical Optimization. Real-time updates on events, politics, business and more.

Harvard gets $1.2M to develop oral antibiotics that kill drug-resistant infections

February 14, 2024

Harvard researchers receive $1.2 million from CARB-X to develop enhanced oral antibiotics for drug-resistant bacteria listed by CDC.

Harvard University United States Andrew Myers Erin Duffy Harvard University Andrewg Myers Research Group Boston University Led

Source: beckershospitalreview.com

Lytic Post-Thrombectomy Improved Stroke Outcomes

February 11, 2022

But a number of problems with clinical trial may require a redo

University Of Cincinnati United States Comunidad Autonoma De Cataluna Angel Chamorro Pooja Khatri American Stroke Association International Conference

Source: medpagetoday.com

Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial | Cerebrovascular Disease | JAMA

February 10, 2022

This randomized clinical trial assesses the effect of intra-arterial alteplase infusion vs placebo on functional outcomes (modified Rankin Scale scores) among p

Eteläuomen Läi United States New Orleans Comunidad Autonoma De Cataluna Cooperativa Invictus Spanish Ministry Of Health

Source: jamanetwork.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Chemical Optimization News Today

Harvard gets $1.2M to develop oral antibiotics that kill drug-resistant infections

Lytic Post-Thrombectomy Improved Stroke Outcomes

Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial | Cerebrovascular Disease | JAMA

Explore More Categories